Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

786
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
786
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

337
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
337
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

557
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
557
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

664
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
664
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

257
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

588
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
588

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Roadmap for AI in GI Fellowship Training.

The American journal of gastroenterology·2026
Same author

A 30-Year Analysis of National Institutes of Health F32 Grants to Internal Medicine Trainees.

Annals of internal medicine·2025
Same author

Post-Chimeric Antigen Receptor T-Cell Therapy Hepatitis B Virus Reactivation After 23 Months of Entecavir Prophylaxis.

ACG case reports journal·2024
Same author

MELD and MELD 3.0: What It Means for Your Practice.

The American journal of gastroenterology·2024
Same author

Use of Phosphatidylethanol Testing in Patients With Liver Disease.

The American journal of gastroenterology·2023
Same author

Immune checkpoint inhibitor-related liver toxicity.

Clinical liver disease·2022

Related Experiment Video

Updated: Apr 6, 2026

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

995

Management options in decompensated cirrhosis.

Neeral L Shah1, Yasmin Pourkazemi Banaei2, Kristen L Hojnowski2

  • 1Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA.

Hepatic Medicine : Evidence and Research
|July 24, 2015
PubMed
Summary

This review details managing chronic liver disease complications, including portal hypertension, hepatic encephalopathy, hepatorenal syndrome, and bleeding issues in cirrhosis patients. Effective management is crucial for improving patient outcomes and reducing mortality.

Keywords:
coagulationhepatic encephalopathyhepatorenalportal hypertension

More Related Videos

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
06:00

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Published on: December 30, 2025

550
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.9K

Related Experiment Videos

Last Updated: Apr 6, 2026

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

995
Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
06:00

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Published on: December 30, 2025

550
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.9K

Area of Science:

  • Hepatology
  • Internal Medicine
  • Gastroenterology

Background:

  • Chronic liver injury leads to irreversible scarring (cirrhosis), a significant cause of U.S. mortality.
  • Effective patient management in inpatient and outpatient settings is critical for improving morbidity and mortality rates.
  • Cirrhosis affects numerous patients, necessitating comprehensive care strategies.

Purpose of the Study:

  • To provide an overview of key management areas for patients with cirrhosis.
  • To address outpatient care, including portal hypertension, decompensation, and health maintenance.
  • To review common complications such as hepatic encephalopathy, hepatorenal syndrome, and coagulation disorders.

Main Methods:

  • Literature review focusing on current management strategies for cirrhosis complications.
  • Discussion of pathophysiology, acute treatment, and long-term prevention for hepatic encephalopathy.
  • Analysis of hepatorenal syndrome, coagulation assessment, and bleeding/thrombosis management.

Main Results:

  • Outlines recommendations for outpatient health maintenance and screening in cirrhosis patients.
  • Summarizes pathophysiology and treatment for acute hepatic encephalopathy and strategies for prevention.
  • Details hospital-based management of hepatorenal syndrome and assessment of coagulation profiles.

Conclusions:

  • Comprehensive management of cirrhosis complications is essential for patient survival and quality of life.
  • Addressing portal hypertension, hepatic encephalopathy, hepatorenal syndrome, and coagulation issues improves patient care.
  • This review provides a foundation for managing common, critical complications in cirrhosis patients.